Andreas Janata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andreas Janata has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Fritz Sterz
Department of Emergency Medicine, Medical University of Vienna, 1090 Vienna, Austria
3 shared publications - Wolfgang Weihs
Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria
3 shared publications - Alexandra-Maria Warenits
Department of Emergency Medicine, Medical University of Vienna, 1090 Vienna, Austria
2 shared publications - Andreas Schober
Medical University of Vienna, Vienna, Austria
2 shared publications Sandra Högler
2 shared publications- Akos Tiboldi
Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria
1 shared publication
Latest Publications
- 1 December 2016
- Published by Wolters Kluwer Health in Shock
- Vol. 46 (6) , 704-712
Reduction of Serious Adverse Events Demanding Study Exclusion in Model Development
Extracorporeal life support is a promising concept for selected patients in refractory cardiogenic shock and for advanced life support of persistent ventricular fibrillation cardiac arrest. Animal models of ventricular fibrillation cardiac arrest could help to investigate new treatment strategies for successful resuscitation. Associated procedural pitfalls in establishing a rat model of extracorporeal life support resuscitation need to be replaced, refined, reduced, and reported. Anesthetized male Sprague-Dawley rats (350–600 g) (n = 126) underwent cardiac arrest induced with a pacing catheter placed into the right ventricle via a jugular cannula. Rats were resuscitated with extracorporeal life support, mechanical ventilation, defibrillation, and medication. Catheter and cannula explantation was performed if restoration of spontaneous circulation was achieved. All observed serious adverse events (SAEs) occurring in each of the experimental phases were analyzed. Restoration of spontaneous circulation could be achieved in 68 of 126 rats (54%); SAEs were observed in 76 (60%) experiments. Experimental procedures related SAEs were 62 (82%) and avoidable human errors were 14 (18%). The most common serious adverse events were caused by insertion or explantation of the venous bypass cannula and resulted in lethal bleeding, cannula dislocation, or air embolism. Establishing an extracorporeal life support model in rats has confronted us with technical challenges. Even advancements in small animal critical care management over the years delivered by an experienced team and technical modifications were not able to totally avoid such serious adverse events. Replacement, refinement, and reduction reports of serious adverse events demanding study exclusions to avoid animal resources are missing and are presented hereby.
- 1 December 2016
- Published by Wolters Kluwer Health in Shock
- Vol. 46 (6) , 704-712
Reduction of Serious Adverse Events Demanding Study Exclusion in Model Development
Extracorporeal life support is a promising concept for selected patients in refractory cardiogenic shock and for advanced life support of persistent ventricular fibrillation cardiac arrest. Animal models of ventricular fibrillation cardiac arrest could help to investigate new treatment strategies for successful resuscitation. Associated procedural pitfalls in establishing a rat model of extracorporeal life support resuscitation need to be replaced, refined, reduced, and reported. Anesthetized male Sprague-Dawley rats (350–600 g) (n = 126) underwent cardiac arrest induced with a pacing catheter placed into the right ventricle via a jugular cannula. Rats were resuscitated with extracorporeal life support, mechanical ventilation, defibrillation, and medication. Catheter and cannula explantation was performed if restoration of spontaneous circulation was achieved. All observed serious adverse events (SAEs) occurring in each of the experimental phases were analyzed. Restoration of spontaneous circulation could be achieved in 68 of 126 rats (54%); SAEs were observed in 76 (60%) experiments. Experimental procedures related SAEs were 62 (82%) and avoidable human errors were 14 (18%). The most common serious adverse events were caused by insertion or explantation of the venous bypass cannula and resulted in lethal bleeding, cannula dislocation, or air embolism. Establishing an extracorporeal life support model in rats has confronted us with technical challenges. Even advancements in small animal critical care management over the years delivered by an experienced team and technical modifications were not able to totally avoid such serious adverse events. Replacement, refinement, and reduction reports of serious adverse events demanding study exclusions to avoid animal resources are missing and are presented hereby.
- Open Access
- 13 June 2016
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-8
Reduced long-term memory in a rat model of 8 minutes ventricular fibrillation cardiac arrest: a pilot trial
Evaluating beneficial effects of potential protective therapies following cardiac arrest in rodent models could be enhanced by exploring behavior and cognitive functions. The Morris Water Maze is a well-known cognitive paradigm to test spatial learning and memory. Behavioral testing with the Morris Water Maze in Sprague–Dawley rats (300 ± 25 g) resuscitated after 8 min of ventricular fibrillation cardiac arrest was carried out 5 and 12 weeks after cardiac arrest (CA) and compared to results of naïve rats (Control). At 5 weeks, within each group latency time to reach the hidden platform (reflecting spatial learning) decreased equally from day 1 to 4 (CA: 105.6 ± 8.2 vs. 8.9 ± 1.2 s, p < 0.001; Control: 75.5 ± 13.2 vs. 17.1 ± 4.5, p < 0.001) with no differences between groups (p = 0.138). In the probe trial 24 h after the last trial, time spent in the target sector (reflecting memory recall) within each group was significantly longer (CA: 25 ± 1.3; Control: 24.7 ± 2.5 s) than in each of the three other sectors (CA: 7.7 ± 0.7, 14.3 ± 2.5, 8.4 ± 0.8 and Control: 7.8 ± 1.2, 11.7 ± 1.5, 10.3 ± 1.6 s) but with no significantly differences between groups. Seven days later (reflecting memory retention), control group animals remained significantly longer in the target sector compared to every other sector, whereas the cardiac arrest group animals did not. Even 12 weeks after cardiac arrest, the single p values showed that the control animals displayed a trend to perform better than the resuscitated animals. Memory recall was impaired early after 8 min of ventricular fibrillation cardiac arrest and might be a more valuable tool for cognitive testing than learning recall after global ischemia due to cardiac arrest.
- 13 June 2016
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-8
Open AccessReduced long-term memory in a rat model of 8 minutes ventricular fibrillation cardiac arrest: a pilot trial
Evaluating beneficial effects of potential protective therapies following cardiac arrest in rodent models could be enhanced by exploring behavior and cognitive functions. The Morris Water Maze is a well-known cognitive paradigm to test spatial learning and memory. Behavioral testing with the Morris Water Maze in Sprague–Dawley rats (300 ± 25 g) resuscitated after 8 min of ventricular fibrillation cardiac arrest was carried out 5 and 12 weeks after cardiac arrest (CA) and compared to results of naïve rats (Control). At 5 weeks, within each group latency time to reach the hidden platform (reflecting spatial learning) decreased equally from day 1 to 4 (CA: 105.6 ± 8.2 vs. 8.9 ± 1.2 s, p < 0.001; Control: 75.5 ± 13.2 vs. 17.1 ± 4.5, p < 0.001) with no differences between groups (p = 0.138). In the probe trial 24 h after the last trial, time spent in the target sector (reflecting memory recall) within each group was significantly longer (CA: 25 ± 1.3; Control: 24.7 ± 2.5 s) than in each of the three other sectors (CA: 7.7 ± 0.7, 14.3 ± 2.5, 8.4 ± 0.8 and Control: 7.8 ± 1.2, 11.7 ± 1.5, 10.3 ± 1.6 s) but with no significantly differences between groups. Seven days later (reflecting memory retention), control group animals remained significantly longer in the target sector compared to every other sector, whereas the cardiac arrest group animals did not. Even 12 weeks after cardiac arrest, the single p values showed that the control animals displayed a trend to perform better than the resuscitated animals. Memory recall was impaired early after 8 min of ventricular fibrillation cardiac arrest and might be a more valuable tool for cognitive testing than learning recall after global ischemia due to cardiac arrest.
- 16 September 2011
- Published by Springer Nature in Wiener klinisches Magazin
- Vol. 14 (4) , 6-12
Therapeutische Hypothermie
- 16 September 2011
- Published by Springer Nature in Wiener klinisches Magazin
- Vol. 14 (4) , 6-12
Therapeutische Hypothermie
- 28 February 2010
- Published by Elsevier in Resuscitation
- Vol. 81 (2) , 242-247
Outcome after resuscitation using controlled rapid extracorporeal cooling to a brain temperature of 30°C, 24°C and 18°C during cardiac arrest in pigs
- 28 February 2010
- Published by Elsevier in Resuscitation
- Vol. 81 (2) , 242-247
Outcome after resuscitation using controlled rapid extracorporeal cooling to a brain temperature of 30°C, 24°C and 18°C during cardiac arrest in pigs
- 1 September 2009
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 52 (2) , 168-179
Hypothermia After Cardiac Arrest
- 1 September 2009
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 52 (2) , 168-179
Hypothermia After Cardiac Arrest
- 27 May 2008
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 31 (6) , 676-684
Quality of ECG Monitoring with a Miniature ECG Recorder
Background: Long‐term monitoring of patients at risk of arrhythmias would benefit from a miniaturized device. This study evaluated the quality of electrocardiogram (ECG) signals recorded by a miniaturized ECG recorder. Methods: ECG data were concurrently recorded with an investigational device (Philips Medical Systems, Seattle, WA, USA) and a Holter recorder from patients with cardiac‐related symptoms at the emergency department of a tertiary care university hospital. The device was attached in one of four locations (L1: below left clavicle, L2: midsternal, L3: below left breast, L4: left anterior axillary line in 5th intercostal space). Selected ECG strips were analyzed for atrial activity, QRS width, and basic rhythm by two physicians. Patients were divided into groups based on their number of strips (A 2–5, B 6–9, C 10–21) for descriptive presentation of the data. For statistical analyses, nonlinear mixed‐effects models were used. Results: In 90 patients, 574 pairs of strips were analyzed. In L1 (n = 37), agreement between the device and the Holter recorder on presence of P wave was 58–80% in groups A–C and in L2 (n = 28):94–98%, L3 (n = 12):30–72%, and L4 (n = 13):0–70%; on PR interval in L1:58–80%, L2:94–98%, L3:30–62%, and L4:0–70%; on rhythm in L1:56–79%, L2:94–98%, L3:30–62%, and L4:0–70%; on QRS width in L1:86–100%, L2:88–98%, L3:100%, and L4:96–100%. The agreement of L2 in the parameters P wave, PR interval, and rhythm diagnosis was better than in the other locations (P < 0.01). Conclusions: A miniature ECG monitor provided accurate assessment of atrial beats and rhythm diagnosis at a midsternal location and of QRS width at all locations.
- 27 May 2008
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 31 (6) , 676-684
Quality of ECG Monitoring with a Miniature ECG Recorder
Background: Long‐term monitoring of patients at risk of arrhythmias would benefit from a miniaturized device. This study evaluated the quality of electrocardiogram (ECG) signals recorded by a miniaturized ECG recorder. Methods: ECG data were concurrently recorded with an investigational device (Philips Medical Systems, Seattle, WA, USA) and a Holter recorder from patients with cardiac‐related symptoms at the emergency department of a tertiary care university hospital. The device was attached in one of four locations (L1: below left clavicle, L2: midsternal, L3: below left breast, L4: left anterior axillary line in 5th intercostal space). Selected ECG strips were analyzed for atrial activity, QRS width, and basic rhythm by two physicians. Patients were divided into groups based on their number of strips (A 2–5, B 6–9, C 10–21) for descriptive presentation of the data. For statistical analyses, nonlinear mixed‐effects models were used. Results: In 90 patients, 574 pairs of strips were analyzed. In L1 (n = 37), agreement between the device and the Holter recorder on presence of P wave was 58–80% in groups A–C and in L2 (n = 28):94–98%, L3 (n = 12):30–72%, and L4 (n = 13):0–70%; on PR interval in L1:58–80%, L2:94–98%, L3:30–62%, and L4:0–70%; on rhythm in L1:56–79%, L2:94–98%, L3:30–62%, and L4:0–70%; on QRS width in L1:86–100%, L2:88–98%, L3:100%, and L4:96–100%. The agreement of L2 in the parameters P wave, PR interval, and rhythm diagnosis was better than in the other locations (P < 0.01). Conclusions: A miniature ECG monitor provided accurate assessment of atrial beats and rhythm diagnosis at a midsternal location and of QRS width at all locations.